Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 1/20 | 0.47 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.43 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.43 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.42 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.41 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.40 |
| ▸ | PRNP | P04156 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10031370 | 1.00 | CYP1A2 (0.48) | CYP1A2CYP2A6BACE1HSD17B1HSD17B2 | |
| SCHEMBL20111029 | 0.80 | KDM4E (0.40) | RAB9AKDM4EMAPK1PPARGNCF1 | |
| SCHEMBL10031374 | 0.80 | HTT (0.51) | CYP1A2BACE1PDE3BPDE3ACYP3A4 | |
| SCHEMBL20932902 | 0.80 | MAPT (0.56) | CYP1A2CYP2A6BACE1RAB9ACYP3A4 | |
| SCHEMBL18252673 | 0.79 | HTT (0.50) | CYP1A2PDE3BPDE3ACYP3A4CYP2C19 | |
| SCHEMBL13923222 | 0.79 | PDE4A (0.41) | CYP3A4KDM4ETSHRALDH1A1MAPT | |
| SCHEMBL20111032 | 0.78 | CA2 (0.49) | CA2CYP3A4KDM4EALDH1A1MAPT | |
| SCHEMBL10031363 | 0.77 | CYP2A6 (0.52) | CYP1A2CYP2A6BACE1RAB9AKDM4E | |
| SCHEMBL4730464 | 0.77 | KDM4E (0.53) | CYP1A2BACE1PDE3BPDE3ARAB9A | |
| SCHEMBL17037120 | 0.77 | CYP2A6 (0.52) | CYP1A2CYP2A6BACE1RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9680112-B2 | Semiconductor composition | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-06-13 | — | — | US | disclosed |
| US-9203038-B2 | Electronic device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-12-01 | — | — | US | disclosed |
| US-20150123041-A1 | SEMICONDUCTOR COMPOSITION | SAMSUNG ELECTRONICS CO LTD (KR) | 2015-05-07 | — | — | US | disclosed |
| US-20150053961-A1 | ELECTRONIC DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2015-02-26 | — | — | US | disclosed |
| US-8963131-B2 | Electronic device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-02-24 | — | — | US | disclosed |
| US-8945425-B2 | Semiconductor composition | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-02-03 | — | — | US | disclosed |
| US-8643001-B2 | Semiconductor composition | SAMSUNG ELECTRONICS CO. LTD. (KR) | 2014-02-04 | — | — | US | disclosed |
| US-20120313081-A1 | ELECTRONIC DEVICE | XEROX CORPORATION (US) | 2012-12-13 | — | — | US | disclosed |
| US-20120261648-A1 | SEMICONDUCTOR COMPOSITION | XEROX CORPORATION (US) | 2012-10-18 | — | — | US | disclosed |
| US-20120161110-A1 | SEMICONDUCTOR COMPOSITION | XEROX CORPORATION (US) | 2012-06-28 | — | — | US | disclosed |
| US-20090043113-A1 | Heteroacene compound, organic thin film including a heteroacene compound and electronic device including an organic thin film | SAMSUNG ELECTRONICS CO., LTD. | 2009-02-12 | — | — | US | disclosed |
| US-20090043113-A1 | Heteroacene compound, organic thin film including a heteroacene compound and electronic device including an organic thin film | SAMSUNG ELECTRONICS CO., LTD. | 2009-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090043113-A1 | Heteroacene compound, organic thin film including a heteroacene compound and electronic device including an organic thin film | EED, TEAD2, TEAD1 | CYP1A2 847/4885CYP2A6 1708/4885BACE1 588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.